Role and prognostic significance of CD44s expression in colorectal cancer

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2671-2675

  Visca, Paolo ^a   Del Nonno, Franca ^a   Botti, Claudio ^a   Marandino, Ferdinando ^a   Sebastiani, Valeria ^b   Di Tondo, Ugo ^b   Donnorso, Raffaele Perrone ^a   Trombetta, Giorgio ^a   Filippi, Stefania ^a   Alo, Piero Luigi ^b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Carcinogenesis; CD44s; Colorectal; Immunohistochemistry; Prognosis

Indexed keywords

HERMES ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; COLON ADENOCARCINOMA; COLON ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADENOMA; ANTIGENS, CD44; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROTEIN ISOFORMS; SURVIVAL ANALYSIS;

EID: 0036765679     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Visca P, Alo PL, Del Nonno F, Botti C, Trombetta G, Marandino F, Filippi F, Di Tondo U and Donnorso RP: Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Clin Cancer Res 5(12): 4111-4118, 1999.
2. Melhem MF, Meisler AI, Finley GG, Bryce WH, Jons MO, Tribby II, Pipas JM and Koski RA: Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors. Cancer Res 52: 5853-5864, 1992.
3. Sinicrope FA, Ruan RS, Cleary KR, Stephens LC, Lee JJ and Levin B: bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55: 237-241, 1995.
4. Coppola D, Hyacinthe M, Fu L, Cantor AB, Karl R, Marcet J, Cooper DL, Nicosia SV and Cooper HS: CD44V6 expression in human colorectal carcinoma. Hum Pathol 29(6): 627-635, 1998.
5. Furuta K, Zahurak M, Yang XL, Rosada C, Goodman SN, August JT and Hamilton SR: Relationship between CD44 expression and cell proliferation in epithelium and stroma of colorectal neoplasms. Am J Pathol 149(4): 1147-1155, 1996.
6. Friedrichs K, Franke F, Lisboa BW, Kugler G, Gille I, Terpe HJ, Holzel F, Maass H and Gunther U: CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55(22): 5424-5433, 1995.
7. Yamaguchi A, Urano T, Goi T, Saito M, Takeuchi K, Hirose K, Nakagawara G, Shiku H and Fukuwara K: Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 14(4): 122-1127, 1996.
8. Stamenkovic I, Amiot M, Pesando JM and Seed B: A lymphocyte molecule implicated in lymphnode homing is a member of the cartilage link protein family. Cell 24(56): 1057-1062, 1989.
9. Nagasaka S, Tanabe KK, Bruner JH, Saya H, Sawaya RE and Morrison RS: Alternative RNA splicing of the hyaluronic receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 82(5): 858-863, 1995.
10. Jalkanen S, Bargatze RF, Herron LR and Butcher EC: A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16(10): 1195-1202, 1986.
11. Furuta K, Zahurak M, Goodman SN, Hamilton SR and August JT: CD44 expression in the stromal matrix of colorectal cancer: association with prognosis. Clin Cancer Res 4: 21-29, 1998.
12. Vogel H, Butcher EC and Picker LJ: H-CAM expression in the human nervous system: evidence for a role in diverse glial interactions. J Neurocytol 21: 363-373, 1992.
13. Gallatin WM, Wayner EA, Hoffman PA, St John T, Butcher EC and Carter WG: Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc Natl Acad Sci 86(12): 4654-4658, 1989.
14. Coppola D, Clarke M, Landreneau R et al.: Bcl-2, p53, CD44 and CD44V6 isoform expression in neuroendocrine tumors of the lung. Mod Pathol 9: 484-490, 1996.
15. Combaret V, Gross N, Lasset C, Frappaz D, Peruisseau G, Philip T, Beck D and Favrot MC: Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 14(1): 25-34, 1996.
16. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H and Herrlich P: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619, 1995.
17. Mayer B, Jauch KW, Gunther U, Figdor CG, Schildberg FW, Funke I and Johnson J: De novo expression of CD44 and survival in gastric cancer. Lancet 342: 1019-1022, 1993.
18. Gorham H, Sugino T, Woodman AC and Tarin D: Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa. J Clin Pathol 49(6): 482-488, 1996.
19. Wilenga VG, Van der Voort R, Mulder JW, Kruyt PM, Weidema WF, Oosting J, Seldenrijk CA, Van Krimpen C, Offerhaus GJ and Pals ST: CD44 splice variants as prognostic markers in colorectal cancer. Scand J Gastroenterol 33(1): 82-87, 1998.
20. Rotterdam H, Sheahan DG and Sommers SC: In: Biopsy Diagnosis of the Digestive Tract. 2nd edition, vol II, Chapter 6, 1993.
21. Hsu S, Raine L and Fanger H: The use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabelled antibody (PAP) procedures. J Pathol 180: 159-265, 1996.
22. Mikami T, Mitomi H, Yanagisawa N, Yoshida T, Tsuruta O and Okayasu I: Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms. Cancer 89(4): 733-740, 2000.
23. Forsberg UH, Ala-Kapee MM, Jalkanen S, Andersson LC and Schroeder J: The gene for human lymphocyte homing receptor is located on chromosome 11. Eur J Immunol 19: 409-412, 1989.
24. Guriec N, Marcellin L, Gairard B et al.: CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma. Clin Exp Med 14: 434-439, 1996.
25. Roye GD, Myers RB, Brown D et al.: CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer 69: 254-258, 1996.
26. Lesley J, Hyman R and Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271-335, 1993.
27. Verkaik NS, Van Weerden WH, Bussemarkers MJ and Van der Kwast TH: Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region. Lab Invest 80(8): 1291-1298, 2000.
28. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, Van de Berg FM, Ponta H, Herrlich P and Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53(20): 4754-4756, 1993.
29. Fox SB, Fawcett J, Jackson DG et al.: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54: 4536-4546, 1994.
30. Takahashi K, Stamenkovic I, Cutler M, Saya H and Tanage KK: CD44 hyaluronate binding influence growth kinetics and tumorigenicity of the human colon carcinomas. Oncogene 11(11): 2223-2232, 1995.
31. Rapponen KM, Eskelinen MJ, Lipponen PK, Alhava E and Kosma YM: Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol 33: 301- 309, 1998.
32. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, Croteau D, Yang XL and Rosada C: Expression of CD44 in human lung tumor. Cancer Res 54: 1381-1387, 1994.
33. Choi SH, Takahashi K, Eto K and Yoon KK: CD44 expression in human colon carcinomas influence growth of liver metastasis. Int J Cancer 85(4): 523-526, 2000.
34. Orzechowski HD, Beckenbach C, Herbst H, Stolzel U, Riecken EO and Stallmach A: Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells. Eur J Cancer 31A(12): 2073-2079, 1995.